Q2 2025 Earnings Call Transcript November 19, 2024 Ryan Weispfenning: Good morning. I’m Ryan Weispfenning, Vice President and ...

Medtronic PLC (MDT) surpasses guidance with robust growth in key segments and raises full-year outlook despite foreign ...

Medtronic (NYSE: MDT) Q2 2025 Earnings Call Nov 19, 2024, 8:00 a.m. ET ...

The company also reported “high-teens growth” of its Micra leadless pacemaker. The Evolut FX+ was approved by the FDA this ...

Delivering on commitments, executing ahead of expectations, and raising guidanceInnovation driving sustained growth across many franchises: TAVR, PFA, Leadless Pacemakers, Diabetes, Spine ...

Medtronic plc (NYSE: MDT) has reported its financial results for the second quarter of fiscal year 2025, showcasing a robust ...

Medtronic is renowned for the pacemakers its people have created. That’s how the company started in the 1950s, with bulky, visible pacemakers. Now, notes Clifton, they are the size of a vitamin ...

electric pacemaker. For the first time it was possible to keep a patient alive during ventricular asystole lasting for hours to days. This procedure may prove valuable in many clinical situations.

“The Orchestra BioMed team is focused on execution of the BACKBEAT global pivotal study alongside our strategic partner, Medtronic. We are excited about the enthusiasm we ... CNT™, is an ...

"The Orchestra BioMed team is focused on execution of the BACKBEAT global pivotal study alongside our strategic partner, Medtronic ... of hypertension in pacemaker-indicated patients, and a ...

Methods: Using the State Inpatient Database (2016 to 2021), we identified 426 cases of leadless pacemaker (Medtronic MICRA) revision or replacement using ICD-10-PCS codes 02WA3NZ and 02PA3NZ.